Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 18, 2025
Hemagen Diagnostics Revenue
In the fiscal year ending September 30, 2012, Hemagen Diagnostics had annual revenue of $4.04M, down -21.38%. Hemagen Diagnostics had revenue of $875.91K in the quarter ending September 30, 2012, a decrease of -23.58%.
Revenue
4.04M
Revenue Growth
-21.38%
P/S Ratio
n/a
Revenue / Employee
269.47K
Employees
15
Market Cap
16.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2012 | 4.04M | -1.10M | -21.38% |
| Sep 30, 2011 | 5.14M | -78.94K | -1.51% |
| Sep 30, 2010 | 5.22M | -198.76K | -3.67% |
| Sep 30, 2009 | 5.42M | -955.87K | -14.99% |
| Sep 30, 2008 | 6.37M | 1.89M | 42.07% |
| Sep 30, 2007 | Pro | Pro | Pro |
| Sep 30, 2006 | Pro | Pro | Pro |
| Sep 30, 2005 | Pro | Pro | Pro |
| Sep 30, 2004 | Pro | Pro | Pro |
| Sep 30, 2003 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |